m+Medelevator.RU
← Поиск публикаций
Experimental and therapeutic medicine · 2026

Rare co-occurrence of gastrointestinal stromal tumors and leiomyomas: A case report and review of the literature.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhang Yu, Shi Xiaoqiong, Xie Wenfu, He Meilin, Zhang Shan, Peng Xue, Lei Hao, Li Xulei, Liu Haiying, Shu Qiao, Zou Fangyuan, Wei Mingyong

Аннотация

Gastrointestinal stromal tumors (GISTs) are recognized as the most common neoplasms originating from gastrointestinal mesenchymal tissue. On the other hand, gastric leiomyomas are a common benign neoplasm within the gastrointestinal tract. In general, GISTs are thought to be unrelated to gastric leiomyomas; however, the findings presented in the current study disprove this. The current case report presents a rare case where both GIST and gastric leiomyoma coexisted in a single subepithelial lesion (SEL) at the gastric cardia. Previous studies have confirmed that GIST can originate from smooth muscle cells with a BRAF V600E mutation, which was detected in the present GIST specimen. Notably, simultaneous expression of the KIT and BRAF V600E gene was also observed, challenging the previous assumption that only wild-type GIST would carry the BRAF V600E gene. In conclusion, it is proposed that there may be homology between GISTs and gastric leiomyomas, and the BRAF V600E mutation was the critical trigger. Therefore, the incidence of BRAF V600E might have been underestimated in reality. The present study highlights that clinicians should be aware that GIST and gastric leiomyoma can coexist in the same SEL to avoid misdiagnosis and mistreatment. In the face of the escalating drug resistance rate of GIST, researchers may derive some novel insights from the present findings for GIST treatment and management.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты